Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Gastroenteropancreatic Neuroendocrine Tumor × Ga(III)-DOTATOC × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Gastrointestinal 1 Endocrine 1

Conditions

Neuroendocrine Tumors 3 Meningioma 3 Prostatic Neoplasms 1 Neuroblastoma 1 Neoplasms 1 Glioma 1 Gastro-enteropancreatic neuroendocrine tumor 1 Ganglioneuroma 1 Ganglioneuroblastoma 1 Disease 1 Carcinoid Tumor 1 Breast Cancer Metastatic 1 Advanced Gastroenteropancreatic Neuroendocrine Tumor 1

Interventions

Ga(III)-DOTATOC 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06091748 2025-06-03

Gallium (68Ga) Edotreotide PET/CT for Imaging Patients With Gastrointestinal Pancreatic Neuroendocrine Tumors

Jiangsu HengRui Medicine Co., Ltd.

Phase 3 Recruiting

EndocrineGastrointestinalNET

Advanced Gastroenteropancreatic Neuroendocrine Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡